Benzinga | Feb 9, 2021 04:13PM EST

Bioanalytical Systems Q1 EPS $(0.03) Beats $(0.19) Estimate, Sales $17.90M Beat $15.33M Estimate

Bioanalytical Systems (NASDAQ:BASI) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.19) by 84.21 percent. This is a 57.14 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $17.90 million which beat the analyst consensus estimate of $15.33 million by 16.76 percent. This is a 38.57 percent increase over sales of $12.92 million the same period last year.